Proof-of-concept Study of New Imaging Diagnostic in Patients With Suspected Alzheimer's Disease
Clinical trial NCT05453539 · TERMINATED
Trial details
- NCT number
- NCT05453539
- Sponsor
- Alzeca Biosciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-09
- Primary completion
- 2024-11-08
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.